Leigong Tengnei Zhiruan Gao (雷公藤内酯软膏)雷公藤内酯软膏
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 福建太平洋制药有限公司Chinese legal name: 福建太平洋制药有限公司
主要成分Active Ingredients
- 雷公藤内酯Leigong Tengnei Zhi
药物知识说明
雷公藤内酯是一种在国家药监局注册认定的药品。标注生产企业为福建太平洋制药有限公司。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为:福建太平洋制药有限公司Chinese legal name: 福建太平洋制药有限公司、福建太平洋制药有限公司Chinese legal name: 福建太平洋制药有限公司、福建太平洋制药有限公司Chinese legal name: 福建太平洋制药有限公司。
本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 雷公藤内酯软膏) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 福建太平洋制药有限公司.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 福建太平洋制药有限公司Chinese legal name: 福建太平洋制药有限公司, 福建太平洋制药有限公司Chinese legal name: 福建太平洋制药有限公司, 福建太平洋制药有限公司Chinese legal name: 福建太平洋制药有限公司.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 雷公藤内酯软膏Recorded Chinese name: 雷公藤内酯软膏
- 剂型Dosage form: 乳膏剂Cream
- 规格Specification: 10g:0.2mg10 g:0.2 mg
本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 福建太平洋制药有限公司Chinese legal name: 福建太平洋制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H35021241
关联实体Relationships
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H35021241
Manufacturer
Chinese legal name: 福建太平洋制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H35021241
生产企业
福建太平洋制药有限公司(国产)
适应症
治疗银屑病(牛皮癣)。
用法用量
外用。涂患处,一日2-3次。
不良反应
具有明显的刺激症状,表现为用药后第2-3天局部皮肤潮红、灼烧感、起小水疱、糜烂及有渗液或疼痛,停药1-2天则自然消退,再用药刺激症状可逐渐减轻至可耐受。
禁忌
对本品过敏者禁用。
注意事项
1.银屑病进行期应慎用,以防止疾病加重。
2.不宜用于脓疱性银屑病和红皮病性银屑病。
贮藏
密闭,在凉处保存。
规格
10g:0.2mg
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.